Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells

References

• YadavACollmanRGCNS inflammation and macrophage/microglial biology associated with HIV-1 infectionJ Neuroimmune Pharmacol20094443044719768553
   PubMed Web of Science ®Google Scholar
• EllisRJBadieeJVaidaFCD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapyAIDS201125141747175121750419
   PubMed Web of Science ®Google Scholar
• GrantISacktorNMcArthurJHIV neurocognitive disordersGendelmanHEGrantIEverallIPLiptonSASwindellsSThe Neurology of AIDS2 edNew YorkOxford University Press2005357373
   Google Scholar
• AntinoriAArendtGBeckerJTUpdated research nosology for HIV-associated neurocognitive disordersNeurology200769181789179917914061
   PubMed Web of Science ®Google Scholar
• HeatonRKCliffordDBFranklinDRJrHIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER StudyNeurology201075232087209621135382
   PubMed Web of Science ®Google Scholar
• PersidskyYGendelmanHEMononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infectionJ Leukoc Biol200374569170114595004
   PubMed Web of Science ®Google Scholar
• NathASacktorNInfluence of highly active antiretroviral therapy on persistence of HIV in the central nervous systemCurr Opin Neurol200619435836116914973
   PubMed Web of Science ®Google Scholar
• AlexakiALiuYWigdahlBCellular reservoirs of HIV-1 and their role in viral persistenceCurr HIV Res20086538840018855649
   PubMed Web of Science ®Google Scholar
• McArthurJCSteinerJSacktorNNathAHuman immunodeficiency virus-associated neurocognitive disorders: Mind the gapAnn Neurol201067669971420517932
   PubMed Web of Science ®Google Scholar
• MarraCMZhaoYCliffordDBImpact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performanceAIDS200923111359136619424052
   PubMed Web of Science ®Google Scholar
• PriceRWSpudichSAntiretroviral therapy and central nervous system HIV type 1 infectionJ Infect Dis2008197Suppl 3S29430618447615
   PubMed Web of Science ®Google Scholar
• SosnikAChiappettaDACarcabosoAMDrug delivery systems in HIV pharmacotherapy: what has been done and the challenges standing aheadJ Control Release2009138121519445981
   PubMed Web of Science ®Google Scholar
• McMillanJBatrakovaEGendelmanHECell delivery of therapeutic nanoparticlesProg Mol Biol Transl Sci201110456360122093229
   PubMed Web of Science ®Google Scholar
• BressaniRFNowacekASSinghSPharmacotoxicology of monocyte-macrophage nanoformulated antiretroviral drug uptake and carriageNanotoxicology20115459260521175298
   PubMed Web of Science ®Google Scholar
• DouHDestacheCJMoreheadJRDevelopment of a macrophage-based nanoparticle platform for antiretroviral drug deliveryBlood200610882827283516809617
   PubMed Web of Science ®Google Scholar
• DouHMoreheadJDestacheCJLaboratory investigations for the morphologic, pharmacokinetic, and anti-retroviral properties of indinavir nanoparticles in human monocyte-derived macrophagesVirology2007358114815816997345
   PubMed Web of Science ®Google Scholar
• NowacekASMillerRLMcMillanJNanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug deliveryNanomedicine (Lond)20094890391719958227
   PubMed Web of Science ®Google Scholar
• NowacekAGendelmanHENanoART, neuroAIDS and CNS drug deliveryNanomedicine (Lond)20094555757419572821
   PubMed Web of Science ®Google Scholar
• GorantlaSDouHBoskaMQuantitative magnetic resonance and SPECT imaging for macrophage tissue migration and nanoformulated drug deliveryJ Leukoc Biol20068051165117416908517
   PubMed Web of Science ®Google Scholar
• DouHGrotepasCBMcMillanJMMacrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDSJ Immunol2009183166166919535632
   PubMed Web of Science ®Google Scholar
• BeduneauAMaZGrotepasCBFacilitated monocyte-macrophage uptake and tissue distribution of superparmagnetic ironoxide nanoparticlesPLoS One200942e434319183814
   PubMed Web of Science ®Google Scholar
• NowacekASBalkundiSMcMillanJAnalyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, drug release and antiviral activities in human monocyte-derived macrophagesJ Control Release2011150220421121108978
   PubMed Web of Science ®Google Scholar
• GendelmanHEOrensteinJMMartinMAEfficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytesJ Exp Med19881674142814413258626
   PubMed Web of Science ®Google Scholar
• KanmogneGDSchallKLeibhartJKnipeBGendelmanHEPersidskyYHIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesisJ Cereb Blood Flow Metab200727112313416685256
   PubMed Web of Science ®Google Scholar
• ChaudhuriAYangBGendelmanHEPersidskyYKanmogneGDSTAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrierBlood200811142062207218003888
   PubMed Web of Science ®Google Scholar
• YangBAkhterSChaudhuriAKanmogneGDHIV-1 gp120 induces cytokine expression, leukocyte adhesion, and transmigration across the blood-brain barrier: modulatory effects of STAT1 signalingMicrovasc Res200977221221919103208
   PubMed Web of Science ®Google Scholar
• StoddartCABalesCABareJCValidation of the SCID-hu Thy/Liv mouse model with four classes of licensed antiretroviralsPLoS One200727e65517668043
   PubMed Web of Science ®Google Scholar
• HuangJGautamNBathenaSPUPLC-MS/MS quantification of nanoformulated ritonavir, indinavir, atazanavir, and efavirenz in mouse serum and tissuesJ Chromatogr B Analyt Technol Biomed Life Sci20118792323322338
   PubMed Web of Science ®Google Scholar
• ZhaoRSeitherRBrigleKESharinaIGWangPJGoldmanIDImpact of overexpression of the reduced folate carrier (RFC1), an anion exchanger, on concentrative transport in murine L1210 leukemia cellsJ Biol Chem19972723421207212129261128
   PubMed Web of Science ®Google Scholar
• BeduneauASaulnierPBenoitJPActive targeting of brain tumors using nanocarriersBiomaterials200728334947496717716726
   PubMed Web of Science ®Google Scholar
• WuDPardridgeWMBlood-brain barrier transport of reduced folic acidPharmaceutical Research199916341541910213373
   PubMed Web of Science ®Google Scholar
• PatrickTAKranzDMvan DykeTARoyEJFolate receptors as potential therapeutic targets in choroid plexus tumors of SV40 transgenic miceJ Neurooncol19973221111239120540
   PubMed Web of Science ®Google Scholar
• WangXLiJWangYHFT-T, a targeting nanoparticle, enhances specific delivery of paclitaxel to folate receptor-positive tumorsACS Nano20093103165317419761191
   PubMed Web of Science ®Google Scholar
• KularatneSALowPSTargeting of nanoparticles: folate receptorMethods Mol Biol201062424926520217601
   PubMedGoogle Scholar
• NukolovaNVOberoiHSCohenSMKabanovAVBronichTKFolate-decorated nanogels for targeted therapy of ovarian cancerBiomaterials201132235417542621536326
   PubMed Web of Science ®Google Scholar
• LuJLiZZinkJITamanoiFIn vivo tumor suppression efficacy of mesoporous silica nanoparticles-based drug-delivery system: enhanced efficacy by folate modificationNanomedicine20128221222021703996
   PubMed Web of Science ®Google Scholar
• ReddyJALowPSEnhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulationJ Control Release2000641–3273710640643
   PubMed Web of Science ®Google Scholar
• LuYLowPSFolate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumorsCancer Immunol Immunother200251315316211941454
   PubMed Web of Science ®Google Scholar
• BeduneauAHindreFClavreulALerouxJCSaulnierPBenoitJPBrain targeting using novel lipid nanovectorsJ Control Release20081261444918055056
   PubMed Web of Science ®Google Scholar
• KaurAJainSTiwaryAKMannan-coated gelatin nanoparticles for sustained and targeted delivery of didanosine: in vitro and in vivo evaluationActa Pharm2008581617418337208
   PubMed Web of Science ®Google Scholar
• ChattopadhyayNZastreJWongHLWuXYBendayanRSolid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell linePharm Res200825102262227118516666
   PubMed Web of Science ®Google Scholar
• MahajanSDRoyIXuGEnhancing the delivery of anti retroviral drug “Saquinavir” across the blood brain barrier using nanoparticlesCurr HIV Res20108539640420426757
   PubMed Web of Science ®Google Scholar
• Cosenza-NashatMAKimMOZhaoMLSuhHSLeeSCCD45 isoform expression in microglia and inflammatory cells in HIV-1 encephalitisBrain Pathol200616425626517107594
   PubMed Web of Science ®Google Scholar
• BucknerCMLuersAJCalderonTMEugeninEABermanJWNeuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDSJ Neuroimmune Pharmacol20061216018118040782
   PubMed Web of Science ®Google Scholar
• NowacekASBalkundiSMcMillanJAnalyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, drug release and antiviral activities in human monocyte-derived macrophagesJ Control Release2011150220421121108978
   PubMed Web of Science ®Google Scholar
• BalkundiSNowacekASVeerhubotlaRSComparative manufacture and cell-based delivery of antiretroviral nanoformulationsInt J Nanomedicine201163393340422267924
   PubMed Web of Science ®Google Scholar